An access deal with Unitaid and CHAI opens the company's chest X-ray software to public programs in 138 countries.
The Abu Dhabi and Sharjah suites use an imaging platform that sharpens…
FastGlioma scored tumor infiltration in unprocessed surgical samples and predicted the sites…
Chinese researchers layered machine learning, docking and dynamics simulation to find HY-18,623,…
An AI that reads routine tumor slides alongside clinical notes separated two…
Hims and Hers is moving weight loss members onto a care engine…
The NYSE-listed BDC devotes about 6.7% of assets to early-stage healthcare AI, from cancer screening to clinic operations.
A virtual-cell model trained on 38 million protein measurements matched real treatment…
A pathology AI trained only on frozen sections matched real surgical decisions…
Stanford Medicine's weeklong Health AI event across eight symposia explored how AI is empowering patients, reshaping medical education, accelerating cancer…
AI is being harnessed to transform humanitarian healthcare, improving disaster response, disease surveillance, mental health…
From ultra-miniature surgical robots to gamified respiratory monitors, HKUST is redefining medical technology with innovations…
AI is streamlining clinical trials and cutting drug development costs, but success hinges on data…
Counsel Health will deliver AI-supported chronic care to Medicare beneficiaries from early 2027 under CMS's…
LifeMine is reviving its fungal genome platform with $188M from Bill Gates, Jeff Bezos and…
FDA and CMS hosted 10 AI health companies at a private demo day as they…
Despite financial headwinds, AI strategies can help healthcare systems navigate challenges and improve outcomes if…
The generative feature answers clinical questions with cited evidence, with no open-web retrieval and no…
A new World Health Organization report calls for stronger ethics oversight of AI-related health research.
Children's Hospital of Philadelphia turns scans a child already has into surgical-ready heart models in…
New screens show AI-designed minibinders hit PD-L1 but struggle on other cancer targets.